Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Sands

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2011
AAV-mediated liver-directed gene therapyMark S Sands
Pediatric Endocrinology Reviews : PER|October 28, 2014
Mucopolysaccharidosis type VII: A powerful experimental system and therapeutic challengeMark S Sands
Journal of Child Neurology|September 10, 2013
Considerations for the treatment of infantile neuronal ceroid lipofuscinosis (infantile Batten disease)Mark S Sands
Biochemical Society Transactions|September 19, 2014
Astrocytosis in infantile neuronal ceroid lipofuscinosis: friend or foe?Charles Shyng, Mark S Sands
Pediatric Neurology|September 22, 2014
Experimental therapies in the murine model of globoid cell leukodystrophyYedda Li, Mark S Sands
Journal of Neuroscience Research|September 18, 2016
Treatment for Krabbe's disease: Finding the combinationChristina R Mikulka, Mark S Sands
Scientific Reports|July 26, 2017
Primary fibroblasts from CSPα mutation carriers recapitulate hallmarks of the adult onset neuronal ceroid lipofuscinosisBruno A Benitez, Mark S Sands
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
CNS-directed gene therapy for lysosomal storage diseasesMark S Sands, Mark E Haskins
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 21, 2006
Gene therapy for lysosomal storage diseasesMark S Sands, Beverly L Davidson
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 28, 2011
The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosisShannon L Macauley, Milos Pekny, Mark S Sands
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2011
AAV-mediated liver-directed gene therapyMark S Sands
Pediatric Endocrinology Reviews : PER|October 28, 2014
Mucopolysaccharidosis type VII: A powerful experimental system and therapeutic challengeMark S Sands
Journal of Child Neurology|September 10, 2013
Considerations for the treatment of infantile neuronal ceroid lipofuscinosis (infantile Batten disease)Mark S Sands
Biochemical Society Transactions|September 19, 2014
Astrocytosis in infantile neuronal ceroid lipofuscinosis: friend or foe?Charles Shyng, Mark S Sands
Pediatric Neurology|September 22, 2014
Experimental therapies in the murine model of globoid cell leukodystrophyYedda Li, Mark S Sands
Journal of Neuroscience Research|September 18, 2016
Treatment for Krabbe's disease: Finding the combinationChristina R Mikulka, Mark S Sands
Scientific Reports|July 26, 2017
Primary fibroblasts from CSPα mutation carriers recapitulate hallmarks of the adult onset neuronal ceroid lipofuscinosisBruno A Benitez, Mark S Sands
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
CNS-directed gene therapy for lysosomal storage diseasesMark S Sands, Mark E Haskins
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 21, 2006
Gene therapy for lysosomal storage diseasesMark S Sands, Beverly L Davidson
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 28, 2011
The role of attenuated astrocyte activation in infantile neuronal ceroid lipofuscinosisShannon L Macauley, Milos Pekny, Mark S Sands
Pageof 11